Khandpur Umang, Haile Bereket, Makary Mina S
Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Clin Med Insights Oncol. 2024 Oct 18;18:11795549241285390. doi: 10.1177/11795549241285390. eCollection 2024.
Renal cell carcinoma (RCC) is the most common primary renal malignancy. Prevalence of RCC in developed countries has slowly increased. Although partial or total nephrectomy has been the first-line treatment for early-stage RCC, improved or similar safety and treatment outcomes with locoregional therapies have challenged this paradigm. In this review, we explore locoregional techniques for early-stage RCC, including radiofrequency ablation, cryoablation, and microwave ablation with a focus on procedural technique, patient selection, and safety/treatment outcomes. Furthermore, we discuss future advances and novel techniques, including radiomics, combination therapy, high-intensity focused ultrasound, and catheter-directed techniques.
肾细胞癌(RCC)是最常见的原发性肾脏恶性肿瘤。在发达国家,RCC的患病率一直在缓慢上升。尽管部分或全肾切除术一直是早期RCC的一线治疗方法,但局部区域治疗具有改善或相似的安全性和治疗效果,这对这一模式提出了挑战。在本综述中,我们探讨了早期RCC的局部区域技术,包括射频消融、冷冻消融和微波消融,重点关注操作技术、患者选择以及安全性/治疗效果。此外,我们还讨论了未来的进展和新技术,包括放射组学、联合治疗、高强度聚焦超声和导管导向技术。